Guikai George Wu
Chief Executive Officer at Amberstone Biosciences, Inc.
Profile
Guikai George Wu is the founder of Amberstone Biosciences, Inc. He currently holds the titles of President, CEO, and Chief Financial Officer at the company.
The company was founded in 2018.
Guikai George Wu active positions
Companies | Position | Start |
---|---|---|
Amberstone Biosciences, Inc.
Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Chief Executive Officer | 2017-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Amberstone Biosciences, Inc.
Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Health Technology |
- Stock Market
- Insiders
- Guikai George Wu